The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

NCT00293176 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

821

Enrollment

INDUSTRY

Sponsor class

Conditions

Memory Loss

Interventions

DRUG: Donepezil Hydrochloride
DRUG: Placebo

Sponsor

Eisai Inc.

Collaborators

[object Object]